You are here:  Home
Latest news

EU Commission approves Xadago (safinamide) for mid-late stage Parkinson's disease patients

Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic are
Read more

Parkinson's disease patients have reduced visual contrast acuity

Patients with Parkinson's disease (PD) often have difficulties with visual acuity in low-contrast images.
Read more

Researchers develop a molecule that may slow Parkinson's disease

Parkinson's disease arises when misshapen proteins form fibrils that kill brain cells. Now, researchers have made a sticky pe
Read more
3 reasons to become a member
Free subscription to our journal
Access to hot scientific items
Discounts to our publications
PRDAssociation: Please check out our eCME online courses!!!
1 year, 8 months ago
Members only